Comparison
Companies and funds side by side across all metrics. The best value in each row is highlighted.
Performance from the same starting point
All series start at 100 on the same day. The price is adjusted for dividends.
Green background = the best value in the row (the lowest one for cost metrics).
| Loading… |
Compared securities
- NewAmsterdam Pharma Company N.V. (NAMS): price 19,39 USD, market cap 2,33 mld. USD
- Mineralys Therapeutics, Inc. (MLYS): price 14,48 USD, market cap 1,27 mld. USD